Dynasore (A1605): A Precision Dynamin GTPase Inhibitor for Endocytosis Research

Executive Summary: Dynasore is a cell-permeable, noncompetitive inhibitor of dynamin GTPase activity with an IC50 of 15 μM, targeting dynamin1, dynamin2, and Drp1 (APExBIO, 2024). It effectively and reversibly blocks dynamin-dependent endocytosis, including clathrin-mediated pathways, in multiple cell types (Wei et al., 2019, DOI). Dynasore is insoluble in water and ethanol but dissolves readily in DMSO at ≥16.12 mg/mL, requiring warming or sonication for optimal solubilization. The compound's selectivity and reversibility make it indispensable for mechanistic studies of vesicle trafficking, signal transduction, and disease modeling. Proper storage at -20°C preserves Dynasore's stability for several months, ensuring experimental reproducibility.

Biological Rationale

Dynamin GTPases are critical for membrane remodeling events, including clathrin-mediated endocytosis, vesicle budding, and organelle division. Inhibition of these enzymes allows researchers to dissect the functional roles of dynamin-dependent pathways in signal transduction, synaptic function, protein biosynthesis, and membrane trafficking (Wei et al., 2019). Dynasore, developed by APExBIO, is a tool compound designed for the selective inhibition of these GTPases. Experimental models consistently employ Dynasore to block endocytosis, revealing the essential contribution of dynamin to cellular uptake mechanisms in both mammalian and insect cells.

Mechanism of Action of Dynasore

Dynasore acts as a noncompetitive inhibitor of dynamin GTPase activity, binding to the enzyme and preventing GTP hydrolysis without directly competing with GTP substrates. It inhibits dynamin1, dynamin2, and Drp1, with a reported IC50 of 15 μM under standard in vitro assay conditions (APExBIO). By halting GTP hydrolysis, Dynasore blocks the conformational changes required for dynamin-mediated membrane fission. This results in the rapid and reversible cessation of clathrin-mediated endocytosis and related vesicular trafficking events (Wei et al., 2019).

Evidence & Benchmarks

• Dynasore (15–80 μM) inhibits clathrin-mediated endocytosis in Drosophila S2 cells, sharply reducing uptake of extracellular pathogens (Wei et al., 2019, DOI).
• Transferrin uptake and synaptic vesicle endocytosis are reversibly blocked by Dynasore in neuronal and cardiac cell models (Macia et al., 2006, PubMed).
• Dynasore does not affect caveola-mediated endocytosis or cholesterol-dependent uptake, supporting its pathway specificity (Wei et al., 2019, DOI).
• Cell viability is preserved in most cell types at ≤80 μM, with minimal off-target toxicity under standard conditions (Macia et al., 2006, PubMed).

For a scenario-driven, laboratory-focused discussion of Dynasore’s application, see this article; the current review provides updated mechanistic rationale and new disease model context.

Applications, Limits & Misconceptions

Principal Uses

• Dissection of clathrin-mediated endocytosis in mammalian and invertebrate cells.
• Analysis of synaptic vesicle cycling and neurotransmitter release in neuronal systems.
• Investigation of vesicular trafficking pathways in cancer and neurodegenerative disease models.
• Study of host-pathogen interactions, including inhibition of pathogen entry via dynamin-dependent endocytosis (Wei et al., 2019).

For advanced troubleshooting and experimental optimization, see this workflow guide; the present article contributes a comparative mechanistic overview.

Common Pitfalls or Misconceptions

• Dynasore is not effective against caveola-mediated endocytosis or cholesterol-dependent pathways (Wei et al., 2019).
• It is insoluble in water or ethanol; only dissolve in DMSO at ≥16.12 mg/mL and use warming or sonication as needed (APExBIO, product page).
• Dynasore is not suitable for diagnostic or medical use in humans; for research use only (APExBIO).
• Extended incubation (>2 h) at room temperature or repeated freeze-thaw cycles may reduce compound potency or solubility.
• Off-target effects can occur at concentrations >80 μM; always use appropriate vehicle controls.

This review expands upon the translational relevance explored in recent thought-leadership by providing direct protocol parameters and evidence links.

Workflow Integration & Parameters

Preparation: Dissolve Dynasore in DMSO to a stock concentration of ≥16.12 mg/mL. Warm at 37°C or sonicate to aid dissolution. Aliquot and store at -20°C; stable for several months (APExBIO).

Experimental Use: Working concentrations typically range from 15–80 μM, with functional inhibition seen in 10–30 min post-application. Include vehicle (DMSO) controls in all assays. For endocytosis inhibition, apply Dynasore prior to ligand or pathogen exposure and monitor uptake using fluorescence or biochemical readouts.

Assay Design: Use standard buffer conditions (e.g., pH 7.4, 37°C), and limit incubation times to ≤2 h to avoid nonspecific effects. Washout restores endocytosis within 30–60 min, reflecting reversibility (Wei et al., 2019).

For expanded protocol troubleshooting and translational applications in disease models, consult this resource; the current article offers a consolidated, evidence-based summary.

Conclusion & Outlook

Dynasore (SKU A1605) from APExBIO provides a robust, reversible, and pathway-selective approach to studying dynamin-dependent endocytosis and vesicle trafficking. Its proven efficacy in both mammalian and invertebrate systems, together with well-characterized solubility and storage parameters, support its continued use in fundamental and translational research. Ongoing advances in disease modeling, infectious disease studies, and neurobiology will further extend the utility of this compound. For detailed product specifications and ordering, visit the APExBIO Dynasore page.